Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Oura’s latest study indicates that covid-19 can impact biometrics like temperature, heart rate, heart rate variability, and sleep up to 2.5 days before symptoms and for several weeks after.
medRxiv - The Preprint Server for Health Sciences...
The rapid increase in real-time health information collected from wearable devices has allowed digital biomarkers to emerge as a promising tool to support perioperative care, including surgical prehabilitation, intra-operative guidance, and post-operative monitoring.
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.
Wearable devices that measure physiological and behavioral signals have become commonplace. There is growing evidence that these devices can have a meaningful impact promoting healthy behaviors, detecting diseases, and improving the design and implementation of treatments.
Wearable devices that measure physiological and behavioral signals have become commonplace. There is growing evidence that these devices can have a meaningful impact promoting healthy behaviors, detecting diseases, and improving the design and implementation of treatments.
The research initiative aims to enhance the Galaxy Watch’s sleep apnea detection feature and ultimately create AI-powered tools for proactive sleep health management.
The research initiative aims to enhance the Galaxy Watch’s sleep apnea detection feature and ultimately create AI-powered tools for proactive sleep health management.
Continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) systems have revolutionized diabetes management by delivering real-time, dynamic insights into blood glucose levels. This article provides a concise overview of the evolution of CGM technology, highlights emerging innovations...
From Apple and Samsung to Oura and Withings, the health tech space is changing to not only deliver insights into a person's health but also connect them with medical professionals.
From Apple and Samsung to Oura and Withings, the health tech space is changing to not only deliver insights into a person's health but also connect them with medical professionals
ai baby companion - SiriuXense’s UniWhale AI Baby Companion is the world-first AI-driven baby care system and a CES 2025 Innovation Awards Honoree in the Digital...
FaceHeart CardioMirror - Wearable devices often need skin contact and days of data collection to provide insights into vital signs, whereas the FaceHeart CardioMirror can d...
FIRE1 raised $120 million for its Norm system — a heart failure monitor implant that seeks to keep patients out of the hospital.
These over-the-counter CGMs from health brands Dexcom and Abbott make glucose monitoring affordable and accessible. Here's how they can help you - no prescription necessary.
/PRNewswire/ -- VIV Health is thrilled to announce the upcoming launch of the VIV™ Ring, the world's first smart ring equipped with Generative Sleep aid sound,...
Habitué à proposer des produits atypiques au CES, Withings espère séduire les visiteurs du salon américain cette année avec Omnia.
From fitness trackers to smartwatches, learn how these Health Wearable Monitoring Devices are enhancing wellness and improving patient care.
### Résumé
Cet article présente une liste des 10 meilleurs appareils de surveillance de la santé portables en 2024, allant des bracelets d'activité aux montres connectées, en passant par les systèmes de surveillance continue de la glycémie. Il examine les principales caractéristiques, les prix et les avis de ces différents appareils, ainsi que quelques autres innovations dans le domaine de la santé numérique à surveiller en 2025.
### Points clés
- Les appareils de surveillance de la santé sont de plus en plus populaires pour le suivi de la santé et du bien-être, aidant les utilisateurs à prévenir les maladies chroniques.
- L'Oura Ring (3e génération) est un tracker très précis qui permet de suivre le rythme cardiaque, la température corporelle et la qualité du sommeil.
- La Apple Watch (série 9) combine des fonctionnalités de montre connectée avec des fonctionnalités de santé et de fitness, y compris des fonctions médicales approuvées par la FDA.
- Le Garmin Fenix 7 est un appareil orienté fitness, idéal pour les athlètes grâce à ses nombreuses mesures de performance physique.
- Le Fitbit Charge 6 offre une conception simple et épurée avec des informations précieuses sur l'activité et la santé globale.
- Le bracelet Whoop 4.0 se concentre principalement sur le suivi de la performance et de la récupération pour les athlètes.
- Le Levels CGM suit en continu les fluctuations du glucose, aidant les utilisateurs à faire des choix de mode de vie plus sains.
- Le Withings ScanWatch propose un suivi continu du rythme cardiaque, de l'analyse du sommeil et même un électrocardiogramme.
- L'Embr Wave 2 utilise les sensations thermiques pour réguler activement la température corporelle.
- Le TempDrop est conçu spécifiquement pour aider les femmes à suivre leurs cycles menstruels et leur fertilité.
- Le capteur Freestyle Libre 2 CGM d'Abbott surveille en continu les niveaux de glucose sans nécessiter de piqûre au doigt.
- D'autres innovations à surveiller en 2025 incluent le moniteur de fréquence cardiaque et de saturation en oxygène Owlet pour bébés, l'électrocardiogramme portable Kardia Mobile et le bracelet médical Happy Ring.
En 2024, Samsung est entré sur le marché des montres connectées. Mais, malgré l’arrivée de ce géant sur sa niche, la startup Oura, qui propose des bagues connectées depuis 2013, résiste. Celle-ci a récemment levé 200 millions de dollars, pour une valorisation de plus de 5 milliards de dollars.
Lire l'article complet sur : www.presse-citron.net
Discoveries about heart failure, bleeding strokes, obesity and more made the American Heart Association's list of the most significant advances against heart disease and stroke in 2024.
### Résumé
Le contenu de cet article récapitule les principales avancées de la recherche cardiovasculaire en 2024. Il met en évidence les progrès réalisés dans la prévision et la prévention des maladies cardiovasculaires, le développement de nouveaux traitements pour l'insuffisance cardiaque et l'accident vasculaire cérébral, ainsi que l'utilisation bénéfique de médicaments anti-obésité. L'article souligne également l'augmentation prévue de la charge des maladies cardiovasculaires dans les années à venir et la nécessité d'agir pour contrôler les facteurs de risque.
### Points clés
- Prévision de l'augmentation de la prévalence des maladies cardiovasculaires et des coûts de santé associés d'ici 2050.
- Identification de prédicteurs précoces des maladies cardiovasculaires dès l'enfance, notamment le cholestérol élevé, l'hypertension et le comportement sédentaire.
- Développement d'un nouvel outil, PREVENT, pour mieux estimer le risque cardiovasculaire.
- Bénéfices étendus des médicaments anti-obésité pour réduire les complications cardiovasculaires, rénales et l'insuffisance cardiaque.
- Progrès dans le traitement de l'insuffisance cardiaque, notamment avec le finerenone et la réparation de la valve mitrale.
- Nouvelles stratégies de gestion de la cardiomyopathie hypertrophique obstructive.
- Utilisation d'une pompe à microflux pour réduire les risques mortels du choc cardiogénique.
- Lien potentiel entre l'exposition aux nanoplastiques et un risque accru de maladie cardiovasculaire.
- Exploration de nouveaux traitements pour l'hémorragie intracérébrale.
- Remise en question de la prescription systématique de bêtabloquants pour tous les survivants d'infarctus.
A new generation of wearable sensors will fundamentally change medicine. Researchers at ETH Zurich and international experts have now published an overview showing what is possible with such sensors and what questions their developers should consider to ensure their successful future use.
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients.
Background: Effective self-management is crucial in diabetes care. This study investigates the impact of Personal Health Records (PHR) on diabetes management and person self-management behaviors. Methods: Retrospective cohort study was conducted involving individuals with diabetes using insulin...
Sleep tracking by consumers is becoming increasingly prevalent; yet, few studies have evaluated the accuracy of such devices. We sought to evaluate the accuracy of three devices (Oura Ring Gen3, Fitbit Sense 2, and Apple Watch Series 8) compared to the gold standard sleep assessment (polysomnography (PSG)). Thirty-five participants (aged 20–50 years) without a sleep disorder were enrolled in a single-night inpatient study, during which they wore the Oura Ring, Fitbit, and Apple Watch, and were monitored with PSG. For detecting sleep vs. wake, the sensitivity was ≥95% for all devices. For discriminating between sleep stages, the sensitivity ranged from 50 to 86%, as follows: Oura ring sensitivity 76.0–79.5% and precision 77.0–79.5%; Fitbit sensitivity 61.7–78.0% and precision 72.8–73.2%; and Apple sensitivity 50.5–86.1% and precision 72.7–87.8%. The Oura ring was not different from PSG in terms of wake, light sleep, deep sleep, or REM sleep estimation. The Fitbit overestimated light (18 min; p < 0.001) sleep and underestimated deep (15 min; p < 0.001) sleep. The Apple underestimated the duration of wake (7 min; p < 0.01) and deep (43 min; p < 0.001) sleep and overestimated light (45 min; p < 0.001) sleep. In adults with healthy sleep, all the devices were similar to PSG in the estimation of sleep duration, with the devices also showing moderate to substantial agreement with PSG-derived sleep stages.
Withings has launched BPM Pro 2, the first cellular blood pressure monitor with Patient Insight to provide a holistic view of patient health.
Wearable sensors are increasingly being explored in health care, including in cancer care, for their potential in continuously monitoring patients. Despite their growing adoption, significant challenges remain in the quality and consistency of data collected from wearable sensors. Moreover, preprocessing pipelines to clean, transform, normalize, and standardize raw data have not yet been fully optimized.
What is this study all about?
This study aims to conduct a scoping review of preprocessing techniques used on raw wearable sensor data in cancer care, specifically focusing on methods implemented to ensure their readiness for artificial intelligence and machine learning (AI/ML) applications.
The authors sought to understand the current landscape of approaches for handling issues, such as noise, missing values, normalization or standardization, and transformation, as well as techniques for extracting meaningful features from raw sensor outputs and converting them into usable formats for subsequent AI/ML analysis.
The method adopted here was primarily literature review and analysis: The authors systematically searched IEEE Xplore, PubMed, Embase, and Scopus to identify potentially relevant studies for this review.
The eligibility criteria included (1) mobile health and wearable sensor studies in cancer, (2) written and published in English, (3) published between January 2018 and December 2023, (4) full text available rather than abstracts, and (5) original studies published in peer-reviewed journals or conferences.
Conclusions: While wearable sensors are gaining traction in cancer care, realizing their full potential hinges on the ability to reliably translate raw outputs into high-quality data suitable for AI/ML applications.
This review found that researchers are using various preprocessing techniques to address this challenge, but there remains a lack of standardized best practices. The findings suggest a pressing need to develop and adopt uniform data quality and preprocessing workflows of wearable sensor data that can support the breadth of cancer research and varied patient populations.
Given the diverse preprocessing techniques identified in the literature, there is an urgency for a framework that can guide researchers and clinicians in preparing wearable sensor data for AI/ML applications.
read the unedited paper at https://mhealth.jmir.org/2024/1/e59587/
Apple a récemment reçu l'aval de la FDA pour l'ensemble de sa nouvelle gamme de fonctionnalités de santé dont l’apnée du sommeil fait partie.
Samsung lancera The Ring, sa bague connectée, et de nombreuses nouveautés dès le 27 juillet
Pharma Manager & Geek ... #hcsmeu #hcsmeufr #health20fr
http://www.scoop.it/t/pharma-geek
http://www.tikimee.com/lionel-reichardt
